Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: Results of randomized trial

Annals of Oncology

Volumn 20, Issue 6, 2009, Pages 1001-1007

  Canavese, G ^a   Catturich, A ^a   Vecchio, C ^a   Tomei, D ^a   Gipponi, M ^b   Villa, G ^c   Carli, F ^d   Bruzzi, P ^a   Dozin, Beatrice ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Department of General Surgery ^*  (Italy)

^c Department of Nuclear Medicine   (Italy)

^d Department of Anatomy   (Italy)

Author keywords

Axillary lymph node dissection; Breast cancer; Overall survival; Randomized clinical trial; Regional node recurrence; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; KI 67 ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVENT FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SURVIVAL TIME;

EID: 66149093479     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn746     Document Type: Article

References (20)

1. Pater J, Parulekar W. Sentinel lymph node biopsy in early breast cancer: has its time come? J Natl Cancer Inst 2006; 98: 568-569.
2. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339.
3. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
4. Krag D, Weaver D, Ashikaga T et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998; 339: 941-946.
5. Krag DN. The sentinel node for staging breast cancer: Current review. Breast Cancer 1999; 6: 233-236.
6. Mansel RE, Fallowfield L, Kissin M et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 2006; 98: 599-609.
7. Veronesi U, Paganelli G, Viale G et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst 1999; 91: 368-373.
8. Albertini JJ, Lyman GH, Cox C et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-1822.
9. Giuliano AE, Haigh PI, Brennan MB et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-2559.
10. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003; 89: 648-652.
11. Lyman GH, Giuliano AE, Somerfield MR et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-7720.
12. Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.
13. Krag DN, Anderson SJ, Julian TB et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8: 881-888.
14. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: A metaanalysis [review]. Cancer 2006; 106: 4-16.
15. Zavagno G, De Salvo GL, Scalco G et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: Results of the Sentinella/GIVOM trial. Ann Surg 2008; 247: 207-213.
16. Wong SL, Edwards MJ, Chao C et al. Sentinel lymph node biopsy for breast cancer: Impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001; 192: 684-689; discussion 689-691.
17. Martin RC II, Chagpar A, Scoggins CR et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 2005; 241: 1005-1012; discussion 1012-1015.
18. Veronesi U, Paganelli G, Viale G et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: Update of a randomised controlled study. Lancet Oncol 2006; 7: 983-990.
19. Takei H, Suemasu K, Kurosumi M et al. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Breast J 2006; 12 (5 Suppl 2): S157-S164.
20. Cox C, White L, Allred N et al. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 2006; 13: 708-711.